Modern Healthcare September 5, 2019
Healthcare is dragging its feet on moving from fee-for-service to value-based medicine. Private equity firms buying up high-cost physician specialty practices will further hinder this much-needed evolution.
If policymakers want to expand value-based care—and Trump administration officials say they do—then they need to hit the pause button and take a closer look at the private equity buyout phenomenon. A trend once limited to dermatology, ophthalmology and dentistry is spreading rapidly among practices that are among the costliest in medicine, including orthopedics, gastroenterology and urology.
Anyone who doubts private equity takeovers can financially harm patients and subvert cost control should take a closer look at the balance-billing fiasco. Most of the “out of network” services that lead to large balance bills...